NCT06780709Recruiting
Impact of a Structured Wellness Behavioral Intervention on Quality of Life in NMOSD
Source: ClinicalTrials.gov · Last updated 2 Nov 2026
Brief summary (registry, in English)
This project aims to study whether a structured wellness program intervention can improve quality of life among people living with Neuromyelitis Optica Spectrum Disorder (NMOSD). This pilot will test a multi-modal wellness program tailored to NMOSD patients that includes services from physical therapists, dietitians, social workers, nurse practitioners and cognitive therapists. The trial will be designed as a randomized controlled trial, randomizing patients to immediately starting the program as well as a 6 month delayed start. The intervention would leverage an existing clinical comprehensive MS wellness program at the Corinne Dickinson for Multiple Sclerosis (MS) at Mount Sinai Medical Center. The primary endpoint of this study would be evaluating quality of life, as assessed by MS-Quality of Life -54.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- First submitted
- 13 Jan 2025
- Start date
- 28 Jan 2025
- Primary completion date
- Jan 2028
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Diseases
- Neuromyelitis optica (NMOSD)
- NCT number
- NCT06780709
What you commit to
- Study type: Interventional
- Planned participants: 20
- From 28 Jan 2025 to the primary completion date, Jan 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Inability to participate in study evaluation and/or endpoint measures, or participation in another concurrent randomized controlled trial or wellness based intervention.
Age
- Age\<18
Other
- Inability to voluntarily provide consent for study participation
- Any patients with a relapse within 30 days of randomization or any patients with medical restrictions on physical activity will be excluded.
- Any patients who begin stimulants and/or dalfampridine between enrollment and randomization will be excluded.
Who the study is looking for
- Adults (age ≥18) with NMOSD diagnosed with 2015 NMOSD clinical criteria.
- All EDSS scores will be considered in order to make the intervention accessible to all patients regardless of disability.
- All patients regardless of treatment type will be considered.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Corinne Goldsmith Dickinson Center for MS at Mount Sinai Coordinator of this site? Confirm its status | New York | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.